Profile data is unavailable for this security.
About the company
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
- Revenue in USD (TTM)23.10m
- Net income in USD-51.90m
- Incorporated2006
- Employees193.00
- LocationRapid Micro Biosystems Inc1001 Pawtucket Blvd.LOWELL 01854United StatesUSA
- Phone+1 (978) 349-3200
- Fax+1 (302) 636-5401
- Websitehttps://www.rapidmicrobio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacyte Biotech Inc | 0.00 | -14.82m | 16.75m | 2.00 | -- | 0.538 | -- | -- | -1.64 | -1.64 | 0.00 | 5.74 | 0.00 | -- | -- | 0.00 | -1.53 | -13.35 | -1.62 | -13.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1.81 | -- | -- | -- |
| Nexgel Inc | 4.74m | -3.20m | 19.55m | 19.00 | -- | 4.08 | -- | 4.13 | -0.5535 | -0.5535 | 0.8208 | 0.7688 | 0.4428 | 3.24 | 8.46 | 249,263.20 | -30.72 | -44.61 | -39.92 | -56.19 | 20.14 | 5.02 | -69.38 | -180.98 | 1.41 | -- | 0.1819 | -- | 99.66 | 13.06 | 33.48 | -- | -- | -- |
| Aptorum Group Ltd | 431.38k | -2.82m | 19.86m | 3.00 | -- | 0.757 | -- | 46.04 | -0.9126 | -0.9126 | 0.0954 | 4.80 | 0.0208 | 30.36 | 3.88 | 143,793.30 | -20.92 | -40.45 | -19.62 | -42.36 | 2.45 | -4.04 | -1,006.30 | -1,233.68 | 1.18 | -- | 0.1694 | -- | -66.71 | 2.38 | 71.18 | -- | -78.15 | -- |
| Cara Therapeutics Inc | 16.94m | -122.54m | 20.36m | 55.00 | -- | 0.6831 | -- | 1.20 | -2.26 | -2.26 | 0.3118 | 0.5452 | 0.1392 | 1.34 | 4.35 | 307,963.60 | -100.70 | -35.76 | -115.83 | -40.82 | 75.18 | -- | -723.49 | -162.10 | 5.20 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
| Cumberland Pharmaceuticals, Inc. | 38.83m | -8.42m | 20.86m | 91.00 | -- | 0.7572 | -- | 0.5373 | -0.596 | -0.596 | 2.72 | 1.94 | 0.4542 | 0.8812 | 3.08 | 426,654.70 | -9.83 | -7.03 | -14.07 | -9.52 | 83.54 | 79.95 | -21.65 | -17.64 | 1.21 | -24.56 | 0.3717 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| TherapeuticsMD Inc | 1.20m | -6.20m | 21.10m | 1.00 | -- | 0.7362 | -- | 17.60 | -0.58 | -0.6955 | 0.1103 | 2.49 | 0.0236 | -- | 0.4556 | 1,199,000.00 | -12.19 | -53.35 | -16.34 | -111.61 | 73.89 | 86.67 | -516.93 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Bio Essence Corp | 551.51k | -812.66k | 25.47m | 12.00 | -- | -- | -- | 46.18 | -0.0225 | -0.0157 | 0.015 | -0.0378 | 0.4912 | -- | 1.53 | 45,959.17 | -72.37 | -46.34 | -- | -- | 31.29 | 33.89 | -147.35 | -111.21 | -- | -47.73 | 3.39 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| Acasti Pharma Inc | 0.00 | -12.85m | 25.94m | 32.00 | -- | 0.4202 | -- | -- | -1.46 | -1.46 | 0.00 | 6.57 | 0.00 | -- | -- | -- | -16.86 | -31.68 | -17.45 | -33.95 | -- | -- | -- | -56,271.43 | -- | -6.18 | 0.00 | -- | -- | -- | 69.71 | -- | -47.16 | -- |
| Rapid Micro Biosystems Inc | 23.10m | -51.90m | 28.72m | 193.00 | -- | 0.2706 | -- | 1.24 | -1.20 | -1.20 | 0.5355 | 2.48 | 0.1535 | 1.37 | 4.34 | 119,663.20 | -34.49 | -- | -38.20 | -- | -22.59 | -- | -224.73 | -- | 5.62 | -- | 0.0028 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| Equillium Inc | 37.89m | -12.13m | 28.83m | 44.00 | -- | 1.37 | -- | 0.7608 | -0.3476 | -0.3476 | 1.08 | 0.5983 | 0.6568 | -- | 8.95 | 861,227.30 | -21.02 | -46.81 | -39.66 | -57.36 | -- | -- | -32.01 | -328.35 | -- | -- | 0.00 | -- | 128.97 | -- | 78.64 | -- | 7.48 | -- |
| China Health Industries Holdings, Inc. | 95.95k | -1.36m | 30.17m | 32.00 | -- | -- | -- | 314.41 | -0.0208 | -0.0208 | 0.0015 | -0.0366 | 0.0037 | 0.5035 | 20.57 | 2,998.44 | -5.18 | 3.04 | -6.89 | 3.66 | -5.34 | 69.55 | -1,419.49 | 28.61 | 0.0377 | -- | 1.76 | -- | 41,225.93 | -55.72 | -15.49 | -- | -- | -- |
| KALA BIO Inc | 0.00 | -39.55m | 30.79m | 43.00 | -- | 2.92 | -- | -- | -15.15 | -15.15 | 0.00 | 2.37 | 0.00 | -- | -- | 0.00 | -63.15 | -57.83 | -76.71 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -12.26 | 0.8382 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Cyclo Therapeutics Inc | 1.13m | -19.39m | 32.91m | 8.00 | -- | 53.94 | -- | 29.21 | -1.03 | -1.03 | 0.0557 | 0.0213 | 0.2001 | 0.4155 | 11.12 | 140,806.30 | -344.43 | -132.22 | -17,225.46 | -215.17 | 91.02 | 90.37 | -1,721.63 | -1,114.04 | 0.968 | -- | 0.00 | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| Incannex Healthcare Inc | -100.00bn | -100.00bn | 34.39m | -- | -- | 2.43 | -- | -- | -- | -- | -- | 0.8907 | -- | -- | -- | -- | -- | -54.94 | -- | -59.47 | -- | -- | -- | -1,033.07 | -- | -- | 0.00 | -- | 61.92 | 3.38 | -24.35 | -- | 54.12 | -- |
| Natural Alternatives International, Inc. | 120.20m | -3.31m | 37.02m | 317.00 | -- | 0.4402 | 27.59 | 0.308 | -0.5646 | -0.5646 | 20.53 | 13.56 | 0.8091 | 3.63 | 12.77 | 379,183.00 | -2.23 | 4.90 | -2.56 | 5.93 | 8.85 | 15.98 | -2.75 | 3.80 | 2.44 | -2.71 | 0.0996 | 0.00 | -9.91 | 3.06 | -76.46 | -20.74 | 27.08 | -- |
| Aadi Bioscience Inc | 23.84m | -68.83m | 38.80m | 75.00 | -- | 0.4289 | -- | 1.63 | -2.55 | -2.55 | 0.8848 | 3.68 | 0.1692 | 0.6021 | 4.54 | 267,865.20 | -48.86 | -50.25 | -56.39 | -56.15 | 87.70 | -- | -288.72 | -473.97 | 4.86 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
Data as of Jul 26 2024. Currency figures normalised to Rapid Micro Biosystems Inc's reporting currency: US Dollar USD
23.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kennedy Lewis Management LPas of 31 Mar 2024 | 4.94m | 13.16% |
| Glenview Capital Management LLCas of 31 Mar 2024 | 1.32m | 3.51% |
| BlackRock Advisors LLCas of 31 Mar 2024 | 947.80k | 2.52% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 728.48k | 1.94% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 621.56k | 1.66% |
| Geode Capital Management LLCas of 31 Mar 2024 | 161.15k | 0.43% |
| Next Edge Capital Corp.as of 31 Dec 2023 | 90.00k | 0.24% |
| Millennium Management LLCas of 31 Mar 2024 | 66.19k | 0.18% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 57.39k | 0.15% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 52.08k | 0.14% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
